Literature DB >> 33351861

Mutations altering acetylated residues in the CTD of HIV-1 integrase cause defects in proviral transcription at early times after integration of viral DNA.

Shelby Winans1,2,3, Stephen P Goff1,2,3.   

Abstract

The central function of the retroviral integrase protein (IN) is to catalyze the integration of viral DNA into the host genome to form the provirus. The IN protein has also been reported to play a role in a number of other processes throughout the retroviral life cycle such as reverse transcription, nuclear import and particle morphogenesis. Studies have shown that HIV-1 IN is subject to multiple post-translational modifications (PTMs) including acetylation, phosphorylation and SUMOylation. However, the importance of these modifications during infection has been contentious. In this study we attempt to clarify the role of acetylation of HIV-1 IN during the retroviral life cycle. We show that conservative mutation of the known acetylated lysine residues has only a modest effect on reverse transcription and proviral integration efficiency in vivo. However, we observe a large defect in successful expression of proviral genes at early times after infection by an acetylation-deficient IN mutant that cannot be explained by delayed integration dynamics. We demonstrate that the difference between the expression of proviruses integrated by an acetylation mutant and WT IN is likely not due to altered integration site distribution but rather directly due to a lower rate of transcription. Further, the effect of the IN mutation on proviral gene expression is independent of the Tat protein or the LTR promoter. At early times after integration when the transcription defect is observed, the LTRs of proviruses integrated by the mutant IN have altered histone modifications as well as reduced IN protein occupancy. Over time as the transcription defect in the mutant virus diminishes, histone modifications on the WT and mutant proviral LTRs reach comparable levels. These results highlight an unexpected role for the IN protein in regulating proviral transcription at early times post-integration.

Entities:  

Year:  2020        PMID: 33351861      PMCID: PMC7787678          DOI: 10.1371/journal.ppat.1009147

Source DB:  PubMed          Journal:  PLoS Pathog        ISSN: 1553-7366            Impact factor:   6.823


  69 in total

Review 1.  Retroviral DNA integration.

Authors:  P Hindmarsh; J Leis
Journal:  Microbiol Mol Biol Rev       Date:  1999-12       Impact factor: 11.056

2.  The TRIM family protein KAP1 inhibits HIV-1 integration.

Authors:  Awatef Allouch; Cristina Di Primio; Emanuele Alpi; Marina Lusic; Daniele Arosio; Mauro Giacca; Anna Cereseto
Journal:  Cell Host Microbe       Date:  2011-06-16       Impact factor: 21.023

3.  The HIV-1 Tat protein has a versatile role in activating viral transcription.

Authors:  Atze T Das; Alex Harwig; Ben Berkhout
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

4.  MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA.

Authors:  William M Schneider; Dai-tze Wu; Vaibhav Amin; Sriram Aiyer; Monica J Roth
Journal:  Virology       Date:  2012-02-23       Impact factor: 3.616

5.  Characterizing HIV-1 Splicing by Using Next-Generation Sequencing.

Authors:  Ann Emery; Shuntai Zhou; Elizabeth Pollom; Ronald Swanstrom
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

6.  Amplification, Next-generation Sequencing, and Genomic DNA Mapping of Retroviral Integration Sites.

Authors:  Erik Serrao; Peter Cherepanov; Alan N Engelman
Journal:  J Vis Exp       Date:  2016-03-22       Impact factor: 1.355

7.  In vitro DNA tethering of HIV-1 integrase by the transcriptional coactivator LEDGF/p75.

Authors:  Melissa McNeely; Jelle Hendrix; Katrien Busschots; Eline Boons; Angélique Deleersnijder; Melanie Gerard; Frauke Christ; Zeger Debyser
Journal:  J Mol Biol       Date:  2011-07-29       Impact factor: 5.469

8.  Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication.

Authors:  Michael Topper; Yang Luo; Maria Zhadina; Kevin Mohammed; Leonard Smith; Mark A Muesing
Journal:  J Virol       Date:  2006-12-20       Impact factor: 5.103

9.  A sensitive, quantitative assay for human immunodeficiency virus type 1 integration.

Authors:  Una O'Doherty; William J Swiggard; Deepa Jeyakumar; David McGain; Michael H Malim
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

10.  Molecular mechanisms of retroviral integration site selection.

Authors:  Mamuka Kvaratskhelia; Amit Sharma; Ross C Larue; Erik Serrao; Alan Engelman
Journal:  Nucleic Acids Res       Date:  2014-08-21       Impact factor: 16.971

View more
  7 in total

1.  Genome-wide CRISPR/Cas9 transcriptional activation screen identifies a histone acetyltransferase inhibitor complex as a regulator of HIV-1 integration.

Authors:  Qiong Zhang; Shaobo Wang; Wanyu Li; Edwin Yau; Hui Hui; Parmit Kumar Singh; Vasudevan Achuthan; Maile Ann Young Karris; Alan N Engelman; Tariq M Rana
Journal:  Nucleic Acids Res       Date:  2022-06-17       Impact factor: 19.160

Review 2.  Multimodal Functionalities of HIV-1 Integrase.

Authors:  Alan N Engelman; Mamuka Kvaratskhelia
Journal:  Viruses       Date:  2022-04-28       Impact factor: 5.818

Review 3.  Structure and function of retroviral integrase.

Authors:  Goedele N Maertens; Alan N Engelman; Peter Cherepanov
Journal:  Nat Rev Microbiol       Date:  2021-07-09       Impact factor: 60.633

Review 4.  Silencing of Unintegrated Retroviral DNAs.

Authors:  Stephen P Goff
Journal:  Viruses       Date:  2021-11-09       Impact factor: 5.048

5.  A point mutation in HIV-1 integrase redirects proviral integration into centromeric repeats.

Authors:  Shelby Winans; Hyun Jae Yu; Kenia de Los Santos; Gary Z Wang; Vineet N KewalRamani; Stephen P Goff
Journal:  Nat Commun       Date:  2022-03-18       Impact factor: 14.919

Review 6.  The C-Terminal Domain of HIV-1 Integrase: A Swiss Army Knife for the Virus?

Authors:  Cecilia Rocchi; Patrice Gouet; Vincent Parissi; Francesca Fiorini
Journal:  Viruses       Date:  2022-06-27       Impact factor: 5.818

7.  Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China.

Authors:  Weiguang Fan; Xiaodong Wang; Yuchen Zhang; Juan Meng; Miaomiao Su; Xuegang Yang; Haoxi Shi; Penghui Shi; Xinli Lu
Journal:  Front Genet       Date:  2022-09-14       Impact factor: 4.772

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.